Sep 12, 2022 7:00am EDT Virax BioLabs Presents at H.C. Wainwright's 24th Annual Global Investment Conference
Sep 06, 2022 4:00pm EDT Virax Biolabs Group Limited to Present at H.C. Wainwright's 24th Annual Global Investment Conference in New York, NY
Aug 16, 2022 7:31am EDT Virax Biolabs Announces NASDAQ Closing Bell Ringing to Celebrate Initial Public Offering
Jul 26, 2022 8:00am EDT Virax Biolabs Introduces Monkeypox and Varicella-Zoster Viruses Real-Time PCR Detection Kit
Jul 21, 2022 10:33am EDT Virax Biolabs Group Limited Completes Initial Public Offering; Shares Begin Trading Today on NASDAQ Capital Market as VRAX
Jul 20, 2022 8:20pm EDT Virax Biolabs Group Limited Announces Pricing of $6.75 Million Initial Public Offering
May 09, 2022 9:01am EDT Virax Biolabs Receives Ethical Approval for its Virax Immune COVID-19 Analytical Performance Study from the SBEBO Foundation for the Assessment of Ethics of Biomedical Research
